文献速递肝病

慢性肝病患者减少饮酒动机的相关因素

Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease.
PubMed 文献 · Aliment Pharmacol Ther · 2024-11-11

研究纳入121例来自安全网医院(54例)和两家退伍军人事务医疗系统(67例)肝病门诊的不健康饮酒慢性肝病患者,基线评估焦虑、抑郁、酒精使用障碍筛查及减少饮酒重要性和信心评分。多因素分析显示,退伍军人事务医疗系统站点重要性评分较低0.97分(p=0.02),抑郁症状(PHQ-8≥10 vs <10)和AUDIT评分每增加1分与重要性评分较高相关(估计值1.2和0.08,p<0.05)。肝病病因和严重程度与结局无显著关联。

要点

  • 退伍军人事务医疗系统站点患者减少饮酒重要性评分较安全网医院低0.97分(p=0.02)。
  • 抑郁症状(PHQ-8≥10 vs <10)与重要性评分较高相关(估计值1.2,p<0.05)。
  • AUDIT评分每增加1分与重要性评分较高相关(估计值0.08,p<0.05)。

核心结论

  • 抑郁、酒精问题严重程度和治疗站点可能影响减少饮酒的动机,可为未来基于肝病科的干预提供参考。

研究设计与样本

  • 研究为酒精干预试验的基线分析,纳入121例来自一家安全网医院(N=54)和两家退伍军人事务医疗系统(N=67)肝病门诊的不健康饮酒慢性肝病患者,入组时间为2022年3月至2023年10月。
  • 采用多变量线性回归模型(前向选择)评估预设变量与重要性及信心评分的关联。

主要发现

  • 样本84%为男性,40%为拉丁裔,31%为白人,18%为黑人,11%为其他种族;中位年龄61岁。
  • 中位(Q1-Q3)AUDIT评分为16(12-24),重要性评分为9(6-10),信心评分为8(5-9)。
  • 退伍军人事务医疗系统站点(vs. 安全网医院)参与者重要性评分低0.97分(p=0.02)。
  • 抑郁症状(PHQ-8评分≥10 vs. <10)与重要性评分较高相关(估计值1.2,p<0.05)。
  • AUDIT评分每增加1分与重要性评分较高相关(估计值0.08,p<0.05);肝病病因和严重程度与结局无显著关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Alcohol use is prevalent among hepatology clinic patients with chronic liver disease (CLD). We explored factors associated with the importance and confidence dimensions of motivation to reduce drinking. METHODS: Participants (N = 121) with unhealthy alcohol use (i.e., over NIH guidelines) receiving care in hepatology clinics from a safety-net hospital (SN, N = 54) and two Veterans Affairs Healthcare Systems (VA, N = 67) were enrolled in an alcohol intervention trial from March 2022 through October 2023. Baseline assessments included Generalised Anxiety Disorder (GAD-7), Patient Health Questionnaire (PHQ-8), Alcohol Use Disorders Identification Test (AUDIT), COVID-19 stress; and measures of importance and confidence to decrease alcohol use (readiness rulers, scales of 1-10). Liver disease aetiology and severity were extracted from electronic health records. We performed multivariable linear regression models with forward selection to assess pre-specified variables' associations with importance and confidence. RESULTS: The sample was 84% male, 40% Latino, 31% White, 18% Black and 11% other races; median age was 61 years. Median (Q1-Q3) AUDIT score was 16 (12-24), importance was 9 (6-10) and confidence was 8 (5-9). On multivariable analysis, VA site (vs. SN) participants had a 0.97-point lower importance score (p = 0.02); higher symptoms of depression (PHQ-8 score ≥ 10 vs. < 10) and AUDIT scores (for each point increase) were associated with higher importance score (estimates 1.2 and 0.08, p < 0.05, respectively). Liver disease aetiology and severity were not significantly associated with outcomes. CONCLUSIONS: Depression, alcohol problem severity and treatment site may influence motivation to reduce alcohol use and could inform future hepatology-based interventions.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Satre DD, Dasarathy D, Batki SL, et al. Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease. Aliment Pharmacol Ther. 2024. PMID: 39523996. doi:10.1111/apt.18387

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。